Ismail
Jatoi, MD

Dr. Ismail Jatoi is a professor and chief of the division of surgical oncology and endocrine surgery at UT Health San Antonio. He obtained his bachelor's degree from Washington University in St. Louis, Missouri, and his medicaland doctoratedegrees from St. Louis University. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital in London, England. Dr. Jatoi served in the United Statesmilitary for many years and was a professor of surgery at the Uniformed Services University in Bethesda, Maryland. He retired from the U.S. Army with the rank of colonel. Dr. Jatoi has had a longstanding interest in the treatment of breast cancer, the management of women at increased risk for breast cancer and cancer epidemiology.
Publications
Chiang, H. C., Elledge, R., Larson, P., Jatoi, I., Li, R. & Hu, Y. Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers. Breast Cancer (Auckl) 9, 25-29 (2015). PMID: 26052229; PMCID: PMC4454133
Hsu, P. Y., Hsu, H. K., Hsiao, T. H., Ye, Z., Wang, E., Profit, A. L., Jatoi, I., Chen, Y., Kirma, N. B., Jin, V. X., Sharp, Z. D. & Huang, T. H. Spatiotemporal control of estrogen-responsive transcription in ERalpha-positive breast cancer cells. Oncogene (2015). PMID: 26300005
Jatoi, I. & Parsons, H. M. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias. Breast Cancer Res. Treat. 148, 389-396 (2014) PMID: 25301088; PMCID: PMC4501767

• San Antonio Breast Cancer Symposium to tackle latest issues in research and treatment next week
• Report: Time can change benefits of therapies
• Ravdin to lead Breast Health Clinic at CTRC
• New study suggests breast cancer treatments lose effectiveness over time
• New hope for taming triple-negative breast cancer
• Faculty well represented in professional organizations
• Breast cancer: assessing your risk and learning the latest treatments
• Breast cancer adjuvant therapy benefit can wax and wane over time, study finds
• 37th Annual Breast Cancer Symposium to open with new information and tough topics
• SABCS audit shows local symposium’s global impact
• San Antonio Breast Cancer Symposium to unveil latest advances in research